Piedmont Investment Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-200,815
Closed -$26.3M 362
2020
Q1
$26.3M Buy
200,815
+10,083
+5% +$1.43M 1.04% 14
2019
Q4
$27.8M Buy
190,732
+8,808
+5% +$1.19M 0.96% 15
2019
Q3
$23.5M Buy
181,924
+8,813
+5% +$1.16M 0.91% 18
2019
Q2
$24.1M Sell
173,111
-9,413
-5% -$1.3M 0.97% 13
2019
Q1
$25.5M Buy
182,524
+3,452
+2% +$462K 1.04% 11
2018
Q4
$23.1M Buy
179,072
+236
+0.1% +$32.9K 1.1% 10
2018
Q3
$24.7M Sell
178,836
-92,064
-34% -$12.2M 1.04% 10
2018
Q2
$32.9M Sell
270,900
-276,096
-50% -$34.4M 1.58% 6
2018
Q1
$70.1M Sell
546,996
-176,551
-24% -$23.9M 1.87% 5
2017
Q4
$101M Sell
723,547
-1,514
-0.2% -$211K 2.03% 5
2017
Q3
$94.3M Buy
725,061
+7,833
+1% +$1.04M 2% 5
2017
Q2
$94.9M Buy
717,228
+6,545
+0.9% +$835K 2.11% 4
2017
Q1
$88.5M Buy
710,683
+7,281
+1% +$870K 1.83% 5
2016
Q4
$81M Buy
703,402
+21,288
+3% +$2.46M 1.67% 8
2016
Q3
$80.6M Sell
682,114
-53,357
-7% -$6.47M 1.75% 8
2016
Q2
$89.2M Buy
735,471
+10,773
+1% +$1.22M 1.84% 8
2016
Q1
$78.4M Buy
724,698
+7,666
+1% +$794K 1.65% 9
2015
Q4
$73.7M Buy
717,032
+5,816
+0.8% +$585K 1.55% 11
2015
Q3
$66.4M Buy
711,216
+6,037
+0.9% +$584K 1.5% 9
2015
Q2
$68.7M Buy
705,179
+599,003
+564% +$60M 1.45% 10
2015
Q1
$10.7M Buy
106,176
+25
+0% +$2.54K 0.65% 41
2014
Q4
$11.1M Sell
106,151
-273
-0.3% -$28.8K 0.67% 43
2014
Q3
$11.3M Sell
106,424
-329
-0.3% -$34.1K 0.59% 46
2014
Q2
$11.2M Buy
106,753
+17,632
+20% +$1.78M 0.58% 47
2014
Q1
$8.75M Sell
89,121
-2,460
-3% -$228K 0.48% 46
2013
Q4
$8.39M Buy
91,581
+11,655
+15% +$1.07M 0.45% 47
2013
Q3
$6.93M Sell
79,926
-1,456
-2% -$131K 0.36% 45
2013
Q2
$6.99M Buy
+81,382
New +$6.91M 0.31% 44

Other funds holding JNJ

Piedmont Investment Advisors's JNJ Position: Q2 2020 in Review

Piedmont Investment Advisors sold out of Johnson & Johnson (JNJ) in Q2 2020, closing a stake of 200,815 shares — an estimated $26.3M sold.

Piedmont Investment Advisors first reported a position in JNJ in Q2 2013 and held it in 28 quarters. The position peaked at $101M in Q4 2017. 2,992 funds tracked by Wall St. Rank hold JNJ as of Q2 2020.

  • Piedmont Investment Advisors reported no remaining Johnson & Johnson position as of Q2 2020 after selling out during the quarter.
  • Piedmont Investment Advisors sold 200,815 Johnson & Johnson shares in Q2 2020, an estimated $26.3M.
  • Piedmont Investment Advisors first reported a position in Johnson & Johnson in Q2 2013 and held it in 28 quarters.
  • Piedmont Investment Advisors's Johnson & Johnson position peaked at $101M in Q4 2017.
  • 2,992 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2020.

Based on Piedmont Investment Advisors's 13F filing for Q2 2020.